Showing results (21-30 of 53) with videos related to
Sort By:
Pageof 6
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 23, 2010
Strategies to promote translational research within the European Organisation for Research and Treatment of Cancer (EORTC) Head and Neck Cancer Group: a report from the Translational Research SubcommitteeA Psyrri, L Licitra, D Lacombe, et al.Cancer Treatment Reviews|November 26, 2015
Prognostic role of pretreatment plasma fibrinogen in patients with solid tumors: A systematic review and meta-analysisC Perisanidis, A Psyrri, E E Cohen, et al.Cancer Journal (Sudbury, Mass.)|October 9, 2007
CEOP-21 versus CEOP-14 chemotherapy with or without rituximab for the first-line treatment of patients with aggressive lymphomas: results of the HE22A99 trial of the Hellenic Cooperative Oncology GroupT Economopoulos, A Psyrri, M A Dimopoulos, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 15, 2006
Automated quantitative analysis of DCC tumor suppressor protein in ovarian cancer tissue microarray shows association with beta-catenin levels and outcome in patients with epithelial ovarian cancerA Bamias, Z Yu, P M Weinberger, et al.Cancer Investigation|December 13, 2006
Cisplatin-based chemotherapy for merkel cell carcinoma of the skinD Pectasides, M Pectasides, A Psyrri, et al.Anticancer Research|December 25, 2009
Gastric metastases originating from breast cancer: report of 8 cases and review of the literatureD Pectasides, A Psyrri, K Pliarchopoulou, et al.Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|April 21, 2012
Radiotherapy for Hodgkin's lymphoma: too hard to die?A G Zygogianni, G Kyrgias, A Psyrri, et al.Journal of Andrology|January 13, 2009
Testicular function in poor-risk nonseminomatous germ cell tumors treated with methotrexate, paclitaxel, ifosfamide, and cisplatin combination chemotherapyD Pectasides, E Pectasides, G Papaxoinis, et al.ESMO Open|August 13, 2025
The immunologic landscape of HRAS-mutant head and neck squamous-cell carcinomaP Economopoulou, T Rampias, A Spathis, et al.Oral Diseases|August 16, 2012
HCRP1 expression status is a significant prognostic marker in oral and oropharyngeal cancerC Perisanidis, B Savarese-Brenner, T Würger, et al.Pageof 6